WHO ICTRP trial
piggyBac transposon mediated chimeric antigen receptor gene modified T cells for…
JPRN-jRCTa040190099 · Japan Primary Registries Network (JPRN) · Recruiting
Key facts
| Trial ID | JPRN-jRCTa040190099 |
|---|---|
| Public title | piggyBac transposon mediated chimeric antigen receptor gene modified T cells for CD19 positive acute lymphoblastic leukemia |
| Scientific title | piggyBac transposon mediated chimeric antigen receptor gene modified T cells for CD19 positive acute lymphoblastic leukemia |
| Primary sponsor | Takahashi Yoshiyuki |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Recruiting |
| Study type | Interventional |
| Phase | 1 |
| Countries | Japan |
| Conditions | CD19 positive acute lymphoblastic leukemia |
| Interventions | Administration of CAR-T cells produced from autologous peripheral blood |
| Registration date | Dec 18, 2019 |
| Target size | 12 |
| Registry page | jrct.niph.go.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: